Registry for suspected amniotic fluid embolism patients
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This study builds a long-term registry and sample library for people diagnosed with suspected amniotic fluid embolism (AFE), and for certain related hospital deaths. It helps researchers understand what AFE looks like, how it affects health over time, and how to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal next of kin) must be able to sign and date a consent form
- Your pregnancy event must be diagnosed as AFE, or your case must be suspected in the hospital’s records
- You must be willing to let the study collect pregnancy details, past/future pregnancy info, and current/future health updates
- Biological samples are optional for joining the study
- If the AFE was fatal, you may need a death certificate and proof you’re the legal next of kin
- Your case must fit their hospital window: Hermann Hospital System, within 24 hours of childbirth, between 2012 and 2023
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information on people with atrial fibrillation to understand how different treatments affect their health and quality of life over time.
This study collects health information from people with Fabry disease and specifically from pregnant people with Fabry disease. It helps researchers better understand the condition and how pregnancy affects health, using information you already experience in routine care.
This study tracks pregnancies affected by hemolytic disease of the fetus and newborn (HDFN). It collects information to better understand the condition and improve care. You may join if you are pregnant with a history of a prior affected pregnancy and have a current antibody that could harm your baby.
This study is a registry that tracks the real-world use of a new imaging system called VERAFEYE during heart procedures for atrial fibrillation (irregular heartbeat) or left atrial appendage closure (stroke prevention). By participating, you help doctors learn how well this imaging tool works in everyday practice, and it may help guide your procedure more precisely.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study tracks patients with atrial fibrillation (AF) over time to better understand the condition and improve care. You may be asked to share health information and attend follow-up visits.
Hear when a new Amniotic Fluid Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.